Simply Wall St
Financial/Market news
The goal of Simply Wall St News is to provide readers with updates on the market from a long-term fundamentals perspective. Why are we different to other stockmarket news sites?
We don’t just cover the top 200 stocks
We cover stocks outside the US
We focus on the underlying company fundamentals and not movements in share price
We always use infographics in our articles
Our analysis is always supported by financial data
We started Simply Wall St after realizing that many people are buying stocks only based on hearsay or random hunches and without doing proper research. Often this ends up with them either losing money or underperforming. Source
Actions
Media Outlet details
| Scope | International |
|---|---|
| Language | English |
| Country | Australia |
|
Similarweb UVM |
Request pricing |
|
Comscore UVM |
Request pricing |
Recent Articles
Search ArticlesAtkore Stock And Other U.S. Companies That Could Benefit From Canada Tariffs
Tariffs on Canadian goods have suddenly reshaped a corner of the market, and U.S. manufacturers that already focus on domestic production are now in the spotlight. That shift could redirect demand, alter pricing power, and reward investors who understand which stocks are most exposed to this new trade reality. This article walks through 3 U.S. listed companies linked to the tariff story and explains how each might be affected.
Humana (HUM) Faces A 27% Fair Value Gap On $541.5 Million Overbilling Settlement
Regulatory overbilling settlement puts Humana in focus Humana (HUM) is under closer investor scrutiny after The Villages Health, which it acquired in 2025, agreed to a US$541.5m settlement over alleged Medicare Advantage overbilling using false diagnosis codes. The overbilling was self disclosed before The Villages Health entered bankruptcy, and the government will recover funds through the bankruptcy estate while insurers return credited overpayments.
SentinelOne (S) Stock Looks Reasonable On Cash Flow Yet Rich On Sales
SentinelOne stock has staged a strong recovery in shorter time frames, yet its shares are still down sharply over five years, while a Discounted Cash Flow (DCF) intrinsic value estimate screens the stock as undervalued and traditional market multiples lean the other way. This split, combined with a low overall value score, leaves investors weighing a recent rebound in sentiment against mixed valuation signals.
Adaptive Biotechnologies (ADPT), Why Is It Getting Fresh Attention Now?
Adaptive Biotechnologies (ADPT) has drawn fresh investor attention after its recent share price performance, with the stock last closing at $26.44. The move puts a spotlight on how the company’s immune medicine platform and cancer diagnostics business are currently valued. For context, Adaptive Biotechnologies has shown strong momentum recently, with a 17.41% 1 month share price return, a 74.52% 3 month share price return and a 98.65% 1 year total shareholder return.
Does Five9’s (FIVN) IDC AI Leadership Strengthen Its Contact-Center Moat Or Raise Expectations?
Earlier this month, Five9 was named a Leader in the IDC MarketScape: Worldwide Agentic Contact Center-as-a-Service Platforms 2026 assessment, recognizing its Intelligent CX Platform, Genius AI capabilities, and breadth of enterprise-ready certifications. This independent validation of Five9’s AI-powered contact center platform reinforces its positioning among enterprise buyers who prioritize integrated, omnichannel customer experience solutions.
Is EchoStar’s EPS Beat and Sling NIL Push Altering The Investment Case For EchoStar (ECHO)?
Earlier in August 2026, EchoStar reported its Q2 FY2026 results, delivering a very large earnings-per-share beat even as revenue fell short of expectations, while Sling TV launched a nationwide NIL campaign featuring nine college football players to promote its flexible viewing options. The combination of stronger-than-expected profitability and increasingly positive analyst views has reinforced attention on how EchoStar is executing its connectivity and media ambitions despite revenue pressures.
How Globe Life’s Expanded Buyback and Dividend Strategy Will Impact Globe Life (GL) Investors
Earlier this week, Morgan Stanley analyst Bob Huang highlighted Globe Life after the insurer authorized a new US$2.50 billion share repurchase program alongside its established dividend growth record. The combination of a large buyback authorization and a history of increasing dividends underscores management’s emphasis on returning capital to shareholders through multiple channels.
JetBlue Airways (JBLU) Beat Revenue Estimates, Is The Stock Still Cheap?
JetBlue Airways (JBLU) is in focus after reporting a second quarter loss that was narrower than expected, beating revenue estimates, and unveiling its second BlueHouse lounge at Boston Logan with broader premium access. The Q2 earnings beat and BlueHouse expansion come after a mixed share price pattern for JetBlue Airways, with the stock up 6.54% on a year to date share price return but down 18.5% on a 30 day share price return and showing a 5 year total shareholder return decline of 67.83%.
What Life Time Group Holdings (LTH)'s Ultra Fit Expansion Means For Shareholders
Life Time Group Holdings recently expanded Ultra Fit, its high-intensity Signature Group Training format created by Founder, Chairman and CEO Bahram Akradi, adding more than 200 newly certified coaches and additional classes across over 195 athletic country clubs to meet rising member demand for sprint interval training.
The Bull Case For Deckers Outdoor (DECK) Could Change Following Margin-Focused Record Quarter And Raised EPS Guidance
Earlier this month, Deckers Outdoor reported its first-ever US$1.02 billion quarterly revenue, highlighting strong contributions from the HOKA and UGG brands while lifting full-year fiscal 2027 EPS and gross margin guidance but keeping net sales targets unchanged. An interesting angle is that this improved profitability outlook came even as the company chose not to raise its overall revenue guidance, emphasizing a sharper focus on margin quality rather than pure top-line expansion.